Ovarian serous borderline tumors with micropapillary and cribriform patterns: A study of 40 cases and comparison with 44 cases without these patterns

American Journal of Surgical Pathology

Volumn 23, Issue 4, 1999, Pages 397-409

  Eichhorn, John H ^a   Bell, Debra A ^b   Young, Robert H ^b   Scully, Robert E ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Cribriform; Micropapillary; Prognosis; Serous borderline tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; OVARY TUMOR; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0032935025     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199904000-00004     Document Type: Article

References (27)

1. Aure JC, Høeg K, Kolstad P. Clinical and histological studies of ovarian carcinoma. Long-term follow-up of 990 cases. Obstet Gynecol 1971;37:1-9.
2. Barnhill DR, Kurman RJ, Brady MF, et al. The behavior of Stage I ovarian serous tumors of low malignant potential. A Gynecologic Oncology Group Study. Trans Am Gynecol Obstet Sac 1995;12: 35-40 (Discussion 40-2).
3. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397-403.
4. Bell DA, Weinstock MA, Scully RE. Peritoneal implants in ovarian serous borderline tumors. Histological features and prognosis. Cancer 1988;62:2212-22.
5. Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy. A clinical and pathological study of 109 cases. Cancer 1986;58: 2052-65.
6. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Parthol 1996;20:1319-30.
7. de Nictolis M, Montironi R, Tommasoni S, et al. Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer 1992;70:152-60.
8. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990;65:578-85.
9. Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998;82:1096-103.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
11. Katzenstein AA, Mazur MT, Morgan TE, Kao M. Proliferative serous tumors of the ovary. Histological features and prognosis. Am J Surg Pathol 1978;2:339-55.
12. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 1996;78:278-86.
13. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 1989;74:921-6.
14. Leake JF, Currie JL, Rosenshein NB, Woodruff JD. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992;47:150-8.
15. McCaughey WTE, Kirk ME, Lester W, Dardick I. Peritoneal epithelial lesions associated with proliferative serous tumours of the ovary. Histopathology 1984;8:195-208.
16. Michael H, Roth LM. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer 1986;57: 1240-7.
17. Morrow CP. Malignant and borderline epithelial tumors of ovary: clinical features, staging, diagnosis, intraoperative assessment and review of management. In: M. Coppleson, ed. Gynecologic oncology, 2nd ed. Vol. 2. Edinburgh: Churchill-Livingstone, 1992;889-915.
18. Ozols RF, Rubin SC, Thomas G, Robboy S. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology, 2nd ed. Philadelphia: Lippincott-Raven, 1997:919-86.
19. Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm: International Federation of Gynecology and Obstetrics, 1991.
20. Russell P. Borderline epithelial tumours of the ovary: a conceptual dilemma. Clin Obstet Gynaecol 1984;11:259-77.
21. Scully RE. Ovary. In: Henson DE, Albores-Saavedra J, eds. The pathology of incipient neoplasia, 2ne ed. Philadelphia: W.B. Saunders, 1993:279-93.
22. Segal GH, Hart WR. Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal "implants." Am J Surg Pathol 1992; 16:577-83.
23. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996;20:1331-45.
24. Shepard JH: Revised F.I.G.O. staging for gynecological cancer. Br J Obstet Gynaecol 1989;96:889.
25. Silva EG, Kurman RJ, Russell P, Scully RE. Symposium: ovarian tumors of borderline malignancy. Int J Gynecol Pathol 1996;15: 281-302.
26. Tateno H, Sasano N. Ovarian tumors in Sendai, Japan. General hospital material. In: H. Stalsberg, ed. UICC Technical Report Series. Volume 75. An international survey of distribution of histological types of tumours of the testis and ovary. Geneva: UICC, 1983:291-6.
27. Tavassoli FA. Serous tumors of low malignant potential with early stromal invasion (serous LMP with microinvasion). Mod Pathol 1988;1:407-14.